Visium Asset Management’s Medifast MED Stock Holding History

Visium Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,350,000	Closed	-$40.8M	–	435
2016 Q1	$40.8M	Hold	1,350,000	–	–	0.69%	28
2015 Q4	$41M	Hold	1,350,000	–	–	0.62%	30
2015 Q3	$36.3M	Hold	1,350,000	–	–	0.5%	36
2015 Q2	$43.6M	Hold	1,350,000	–	–	0.62%	30
2015 Q1	$40.5M	Hold	1,350,000	–	–	0.6%	28
2014 Q4	$45.3M	Hold	1,350,000	–	–	0.64%	26
2014 Q3	$44.3M	Hold	1,350,000	–	–	0.65%	22
2014 Q2	$41.1M	Hold	1,350,000	–	–	0.64%	21
2014 Q1	$39.3M	Hold	1,350,000	–	–	0.64%	22
2013 Q4	$35.3M	Hold	1,350,000	–	–	0.69%	22
2013 Q3	$36.3M	Buy	1,350,000 +100,000	+8%	+$2.67M	0.82%	25
2013 Q2	$32.2M	Buy	+1,250,000	New	+$32.8M	0.75%	31

Other funds holding MED

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Visium Asset Management's MED Position: Q2 2016 in Review

Visium Asset Management sold out of Medifast (MED) in Q2 2016, closing a stake of 1,350,000 shares — an estimated $40.8M sold.

Visium Asset Management first reported a position in MED in Q2 2013 and held it in 12 quarters. The position peaked at $45.3M in Q4 2014. 153 funds tracked by Wall St. Rank hold MED as of Q2 2016.

Visium Asset Management reported no remaining Medifast position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 1,350,000 Medifast shares in Q2 2016, an estimated $40.8M.
Visium Asset Management first reported a position in Medifast in Q2 2013 and held it in 12 quarters.
Visium Asset Management's Medifast position peaked at $45.3M in Q4 2014.
153 funds tracked by Wall St. Rank held Medifast as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.